T. Rowe Price Associates’s Trevi Therapeutics TRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$211K Buy
2025
Q1
$203K Buy
2024
Q4
$104K Buy
2024
Q3
$64K Hold
2024
Q2
$57K Buy
2024
Q1
$47K Buy